Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Immunophenotyping profile of CPG 10101, a new TLR9 agonist antiviral for hepatitis C

Immunophenotyping profile of CPG 10101, a new TLR9 agonist antiviral for hepatitis C. Hepatology. 2005; 42(4):148A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.